AD	Alzheimer’s disease
AMPA	amino-3-hydroxy-5-methyl-4-isoxazole propionic acid
APP	amyloid precursor protein
AQP4	aquaporin 4
ATP	adenosine triphosphate
Aβ	amyloid-beta
BBB	blood-brain barrier
BCCAo	bilateral common carotid artery occlusion
CBF	cerebral blood flow
CD	cluster of differentiation
CNS	central nervous system
CRP	C-reactive protein
CSF	cerebrospinal fluid
CSPGs	chondroitin sulphate proteoglycans
ECM	extracellular matrix
GFAP	Glial fibrillary acidic protein
GS	glymphatic system
Iba-1	ionized calcium binding adaptor molecule 1
ICH	intracerebral haemorrhage
IFN-γ	interferon-γ
IL	interleukin
IL-1Ra	interleukin-1 receptor antagonist
LCN2	lipocalin-2
LPS	lipopolysaccharide
MCA	middle cerebral artery
MCAo	middle cerebral artery occlusion
MMP	matrix metalloproteinases
MRI	magnetic resonance imaging
mRS	modified Rankin scale
NF-κB	nuclear factor kappa-light-chain-enhancer of activated B cells
NIHSS	National Institute of Health Stroke Scale
NMDA	N-Methyl-D-aspartate
NO	nitric oxide
OPN	osteopontin
PET	positron emission tomography
PSCI	post-stroke cognitive impairment
PSD	post-stroke dementia
ROS	reactive oxygen species
SN	substantia nigra
SND	secondary neurodegeneration
TNF-α	tumor necrosis factor-alpha
tPA	tissue plasminogen activators
TSPO	translocator protein
VaD	vascular dementia
VPL	ventral posterolateral nucleus
VPM	ventral posteromedial nucleus